1. Home
  2. Browse Decisions
  3. F.Supp.2d
  4. 867 F.Supp.2d
  5. 867 F.Supp.2d 502 (2012)
 

PRONOVA BIOPHARMA NORGE AS v. TEVA PHARMACEUTICALS

Civ. No. 09-286-SLR.

867 F.Supp.2d 502 (2012)

PRONOVA BIOPHARMA NORGE AS, Plaintiff, v. TEVA PHARMACEUTICALS USA, INC., Par Pharmaceutical, Inc. and Par Pharmaceutical Companies, Inc., Defendants.

United States District Court, D. Delaware.

May 29, 2012.

Attorney(s) appearing for the Case

Steven J. Balick, Esq. , Tiffany Geyer Lydon, Esq. and Andrew C. Mayo, Esq. of Ashby & Geddes, Wilmington, DE, of Counsel: James B. Monroe, Esq. , Michael J. Flibbert, Esq. , Maureen D. Queler, Esq. and Robert C. Stanley, Esq. of Finnegan, Henderson, Farabow Garrett & Dunner, LLP, for Plaintiff.

Karen L. Pascale, Esq. and Pilar G. Kraman, Esq. of Young, Conaway, Stargatt & Taylor LLP, Wilmington, DE, of Counsel: David M. Hashmall, Esq. , Frederick H. Rein, Esq. , Annemarie Hassett, Esq. , Gregory T. Sandidge, Esq. and J. Anthony Downs, Esq. of Goodwin Procter LLP, for Defendant Teva Pharmaceuticals USA, Inc.

Frederick L. Cottrell, III, Esq. , Steven J. Fineman, Esq. and Stephen M. Ferguson, Esq. of Richards Layton & Finger, P.A., Wilmington, DE, of Counsel: Daniel G. Brown, Esq. , Mitchell E. Epner, Esq. and Jennifer R. Saionz, Esq. of Wilson Sonsini Goodrich & Rosati, P.C., for Defendants Par Pharmaceutical, Inc. and Par Pharmaceutical Companies, Inc.

OPINION

SUE L. ROBINSON, District Judge.

I. INTRODUCTION

This action arises out of the filing of Abbreviated New Drug Applications ("ANDAs") by Teva Pharmaceuticals, USA, Inc. ("Teva") and Par Pharmaceutical, Inc. and Par Pharmaceutical Companies, Inc. (collectively, "Par") seeking to market versions of Lovaza® (omega-3-acid ethyl esters), used to treat hypertriglyceridemia. Plaintiff Pronova Biopharma Norge AS ("Pronova") is the holder of...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases